A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors

NCT07126665 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumor

Interventions

DRUG: MHB088C for Injection
DRUG: MHB039A for Injection

Sponsor

Minghui Pharmaceutical (Hangzhou) Ltd